glp 1 injection alternative Unusual" Side Effect of Ozempic-Like Drugs Challenges Doctors: Research GLP-1 analogs, new trend in

(HKEX: 1672) has unveiled ASC35, a next-generation GLP-1/GIP dual peptide agonist designed for once-monthly subcutaneous dosing in obesity treatment.

Explore whether the wide health benefits of GLP1 drugssuch as blood sugar control, weight loss, heart and brain protection.

A randomized study found that holding one preprocedure dose of GLP-1 therapy reduced clinically significant residual gastric volume during EGD.

Weekly injectable Semaglutide for lasting weight management

The preliminary data on the effect of GLP-1 RAson asthma in patients with diabetes are promising and merit further trials and research studies.

Agents such as dulaglutide, liraglutide, semaglutide, and tirzepatide differ in pharmacology and dosing, directly influencing perioperative safety, particularly due to their effects on gastric motility and the high frequency of gastrointestinal (GI) adverse events that raise concerns about aspiration and postoperative morbidity in urgent or elective procedures